Hims & Hers Health (HIMS) Competitors $61.21 -1.13 (-1.81%) As of 03:58 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock HIMS vs. NTRA, FMS, OPCH, GH, RDNT, BTSG, SHC, PRVA, SGRY, and CONShould you be buying Hims & Hers Health stock or one of its competitors? The main competitors of Hims & Hers Health include Natera (NTRA), Fresenius Medical Care (FMS), Option Care Health (OPCH), Guardant Health (GH), RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), Privia Health Group (PRVA), Surgery Partners (SGRY), and Concentra Group Holdings Parent (CON). These companies are all part of the "healthcare" industry. Hims & Hers Health vs. Natera Fresenius Medical Care Option Care Health Guardant Health RadNet BrightSpring Health Services Sotera Health Privia Health Group Surgery Partners Concentra Group Holdings Parent Natera (NASDAQ:NTRA) and Hims & Hers Health (NYSE:HIMS) are both large-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their community ranking, earnings, profitability, institutional ownership, analyst recommendations, valuation, dividends, media sentiment and risk. Which has more risk and volatility, NTRA or HIMS? Natera has a beta of 1.79, meaning that its share price is 79% more volatile than the S&P 500. Comparatively, Hims & Hers Health has a beta of 1.84, meaning that its share price is 84% more volatile than the S&P 500. Do institutionals & insiders believe in NTRA or HIMS? 99.9% of Natera shares are held by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are held by institutional investors. 7.6% of Natera shares are held by company insiders. Comparatively, 13.7% of Hims & Hers Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Do analysts prefer NTRA or HIMS? Natera presently has a consensus price target of $182.12, suggesting a potential upside of 17.85%. Hims & Hers Health has a consensus price target of $37.67, suggesting a potential downside of 38.46%. Given Natera's stronger consensus rating and higher possible upside, equities research analysts plainly believe Natera is more favorable than Hims & Hers Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Natera 0 Sell rating(s) 0 Hold rating(s) 16 Buy rating(s) 0 Strong Buy rating(s) 3.00Hims & Hers Health 2 Sell rating(s) 8 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.08 Is NTRA or HIMS more profitable? Hims & Hers Health has a net margin of 8.19% compared to Natera's net margin of -14.01%. Hims & Hers Health's return on equity of 10.97% beat Natera's return on equity.Company Net Margins Return on Equity Return on Assets Natera-14.01% -26.23% -14.27% Hims & Hers Health 8.19%10.97%8.29% Does the media refer more to NTRA or HIMS? In the previous week, Hims & Hers Health had 6 more articles in the media than Natera. MarketBeat recorded 29 mentions for Hims & Hers Health and 23 mentions for Natera. Natera's average media sentiment score of 1.50 beat Hims & Hers Health's score of 0.68 indicating that Natera is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Natera 20 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Very Positive Hims & Hers Health 16 Very Positive mention(s) 3 Positive mention(s) 6 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Which has stronger earnings & valuation, NTRA or HIMS? Hims & Hers Health has lower revenue, but higher earnings than Natera. Natera is trading at a lower price-to-earnings ratio than Hims & Hers Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNatera$1.83B11.52-$434.80M-$1.47-105.12Hims & Hers Health$1.78B7.68-$23.55M$0.6988.71 Does the MarketBeat Community prefer NTRA or HIMS? Natera received 450 more outperform votes than Hims & Hers Health when rated by MarketBeat users. Likewise, 68.90% of users gave Natera an outperform vote while only 34.65% of users gave Hims & Hers Health an outperform vote. CompanyUnderperformOutperformNateraOutperform Votes49468.90% Underperform Votes22331.10% Hims & Hers HealthOutperform Votes4434.65% Underperform Votes8365.35% SummaryNatera and Hims & Hers Health tied by winning 9 of the 18 factors compared between the two stocks. Get Hims & Hers Health News Delivered to You Automatically Sign up to receive the latest news and ratings for HIMS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HIMS vs. The Competition Export to ExcelMetricHims & Hers HealthOffices & clinics of medical doctors IndustryMedical SectorNYSE ExchangeMarket Cap$13.70B$1.88B$5.42B$19.70BDividend YieldN/AN/A5.22%3.84%P/E Ratio139.1231.5126.8335.12Price / Sales7.681.63393.8634.12Price / CashN/A36.0138.2517.51Price / Book38.0216.616.874.78Net Income-$23.55M-$52.07M$3.22B$1.02B7 Day Performance-4.39%3.33%5.65%0.90%1 Month Performance124.70%52.55%13.54%11.10%1 Year Performance228.91%66.15%18.16%5.28% Hims & Hers Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HIMSHims & Hers Health2.3875 of 5 stars$61.21-1.8%$37.67-38.5%+327.9%$13.70B$1.78B139.12650Trending NewsInsider TradeNTRANatera3.3311 of 5 stars$152.65+0.0%$182.12+19.3%+44.0%$20.84B$1.83B-86.733,020Positive NewsAnalyst DowngradeFMSFresenius Medical Care3.1991 of 5 stars$28.93+0.5%$27.80-3.9%+32.5%$16.98B$19.49B23.91123,200Positive NewsAnalyst ForecastGap UpOPCHOption Care Health3.521 of 5 stars$33.06-0.5%$35.50+7.4%+11.1%$5.41B$5.19B27.785,600Positive NewsGHGuardant Health4.7011 of 5 stars$40.11-1.4%$52.32+30.4%+58.7%$4.97B$774.00M-11.271,790News CoveragePositive NewsRDNTRadNet3.4167 of 5 stars$60.12-1.7%$69.75+16.0%+5.6%$4.51B$1.87B-858.798,970BTSGBrightSpring Health Services1.6636 of 5 stars$24.15-1.1%$23.56-2.5%+110.2%$4.21B$11.86B-92.8935,000Positive NewsSHCSotera Health2.1936 of 5 stars$12.65-1.2%$15.80+25.0%+12.8%$3.59B$1.11B50.583,000Positive NewsPRVAPrivia Health Group3.6816 of 5 stars$25.020.0%$27.38+9.5%+47.9%$3.05B$1.80B250.18810SGRYSurgery Partners2.8232 of 5 stars$23.57-1.6%$34.75+47.4%-8.6%$3.02B$3.17B-49.1012,200CONConcentra Group Holdings ParentN/A$22.44-1.2%$28.50+27.0%N/A$2.86B$1.93B16.7511,000Positive News Related Companies and Tools Related Companies NTRA Competitors FMS Competitors OPCH Competitors GH Competitors RDNT Competitors BTSG Competitors SHC Competitors PRVA Competitors SGRY Competitors CON Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:HIMS) was last updated on 5/20/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredHow I profit during chaos…This Guy THRIVES on Chaos Wall Street legend Larry Benedict has thrived through every major market crash. I...Brownstone Research | SponsoredMemorial Day: 59% dividend from Bitcoin (No Crypto Needed)140% Dividends from stocks like Tesla? Discover How for Just $9! For Memorial Day, get the full details of ...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hims & Hers Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hims & Hers Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy HIMS Stock Free HIMS Stock Alerts